Dr. Paul Janssen Award for Biomedical Research
The Dr. Paul Janssen Award for Biomedical Research is a biomedical research award that has been presented to scientists for significant contributions to improving human health since 2006.
history
The science award is named after Paul Janssen (1926–2003), founder of Janssen Pharmaceutica , which has been part of Johnson & Johnson since 1961 . More than 80 drugs have been developed under his leadership. The Dr. Paul Janssen Award for Biomedical Research was presented by Johnson & Johnson for the first time in 2006 and has been annually since 2008.
The winners are nominated by the research community and the winner (s) are selected by a committee of six to eight independent scientists.
In 2010, Anthony Fauci was unable to accept the award due to government policy while working at the state's National Institute of Allergy and Infectious Diseases . A portion of its prize money was donated by the committee to two public health organizations.
Price range
The winners will receive a plastic , a medal and $ 200,000 in prize money (as of 2020), which will be shared among the winners.
The sculpture was designed by Gravity DesignWorks and is handcrafted by glass artist Don Gonzalez. The bottom is made of bronze. A glass ball lies on top of it, from which a glass wall is pierced. It shows how scientific innovation breaks the boundaries of science and medicine.
The gold-framed silver medal (diameter: 3 inches ) is handmade by Caesar Rufo. The front shows Paul Janssen looking into a Petri dish and bears the inscription Inspire Innovate Achieve . On the back it reads What's New? , Janssen's daily question in his laboratory to inspire and encourage his colleagues.
Award winners
- 2006: Craig Mello for discovering RNA interference and its biological functions.
- 2008: Marc Feldmann and Ravinder N. Maini for the discovery of tumor necrosis factor-α as a target for the treatment of rheumatoid arthritis and other chronic inflammations .
- 2009: Axel Ullrich for pioneering applied molecular biology and cloning to discover protein therapies for many diseases, including diabetes and cancer .
- 2010: Erik De Clercq and Anthony Fauci for pioneering work in understanding and combating viral infections , particularly HIV / AIDS .
- 2011: Napoleone Ferrara for his angiogenesis research
- 2012: Victor Ambros and Gary Ruvkun for the discovery of microRNA as a central regulation of gene expression and development.
- 2013: David Julius for the discovery of the molecular mechanism of thermal reception and its role in the perception of acute and inflammatory pain .
- 2014: Jennifer Doudna and Emmanuelle Charpentier for developing a new method for manipulating DNA.
- 2015: Bert Vogelstein for his achievements in cancer research.
- 2016: Yoshinori Ohsumi for his work on the molecular basis of autophagy
- 2017: Douglas C. Wallace for his work on mitochondrial genetics
- 2018: James P. Allison for his work on cancer immunotherapy
- 2019: Franz-Ulrich Hartl and Arthur Horwich for their work on protein folding and chaperones
- 2020: Lewis C. Cantley for his work on phosphoinositide-3-kinases
Web links
Individual evidence
- ↑ a b c About the Award. Janssen Global Services, accessed April 7, 2018 .
- ↑ Award Selection Process. Janssen Global Services, accessed April 7, 2018 .
- ^ Fauci Wins 2010 Janssen Award. National Institutes of Health, October 1, 2010, accessed April 7, 2018 .
- ^ Future of Innovation Dependent on Funding, Collaboration and Idea Exchange. (No longer available online.) Johnson & Johnson, archived from the original on February 19, 2014 ; accessed on February 2, 2014 .